Novartis | Ventas



Sales Cambio Fecha
AbbVie USD 15.1B 642M 2024-12
Alcon AG USD 2.48B 26M 2024-12
Almirall EUR 248.42M 382K 2024-06
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Autolus Therapeutics Ltd 187.5K 9.9M 2024-09
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Fresenius EUR 5.5B 130M 2024-12
Fresenius Medical Care EUR 5.07B 250M 2024-12
Galapagos EUR 75.85M 16M 2024-12
Genmab DKK 64.41B 58.87B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
J&J USD 22.52B 49M 2024-12
Lonza CHF 3.52B 460M 2024-12
Merck EUR 5.42B 152M 2024-12
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Orion EUR 434.4M 36.9M 2024-12
Pfizer USD 17.76B 61M 2024-12
Philips EUR 5.04B 644M 2024-12
Recordati EUR 583.6M 26.19M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
UCB EUR 3.36B 572M 2024-12



Novartis Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.